Incorporating the annual cardiac theme meeting of Stem Cells Australia and the annual meeting of The Australian Network of Cardiac and Vascular Developmental Biologists

From Cardiovascular Development to Regenerative Medicine

WHAT:   The Victor Chang 17th International Symposium

WHEN:   Sunday 6th to Wednesday 9th November  2016

WHERE:  Garvan Auditorium, 384 Victoria Street Darlinghurst, NSW

ENQUIRIES: or (02) 92958763

stemcells crop

This year’s Victor Chang International Symposium will explore the exciting, rapidly moving and controversial field of regenerative medicine and stem cell research.

Despite clinical advances over many decades, heart failure is now in epidemic proportions. One in three will die from cardiovascular causes worldwide. The engrained dogma is that the adult mammalian heart cannot regenerate after injury, instead it forms scars causing irreversible contractile dysfunction and pathology. This is in contrast to the robust regeneration seen in fetal and neonatal mammalian hearts, and in the adult hearts of amphibians and other species.

Inspired by research into these permissive models, researchers have made exciting
discoveries over the last few years that have begun to erode the view that adult
mammalian hearts cannot regenerate after injury. Stem cells are present in adult hearts and their therapeutic potential is being explored in the clinic. Furthermore, genetic, growth factor and bioengineering approaches have shown that heart regeneration can be stimulated and lost capacity rejuvenated after aging. Cardiomyocytes can be coaxed to re-enter the cell cycle and contribute to tissue replacement.

Heart regeneration will inevitably involve a complex dialogue between the different cell types in the damaged organ, including vascular cells and immune cells that invade to clear debris and foster repair. Resolution of fibrous scar and replacement of lost tissue will occur through expansion of existing cardiomyocytes and vascular cells, and may also involve stem cell-based and paracrine support mechanisms. Inevitably, the pathways and processes active during heart development form a template for heart regeneration.

At this year’s Victor Chang International Symposium we will ask how far we have come and how far we need to travel to realise the dream of heart regeneration in humans. The meeting will detail how regeneration in permissive models helps us understand and overcome the roadblocks to heart regeneration in adult humans. It will span new discoveries in heart and vascular development and growth pathways, and explore the role that stem cell systems, immune cells and cardiomyocytes play in heart regeneration and rejuvenation.

It will consider the state-of-the-art in human cardiac stem cell clinical trials, and cover the ethics and public perceptions of stem cell research and provision of unproven
commercial therapies. Regeneration science is embedded in contemporary genetics and genome science, animal biology, bioengineering and clinical medicine, all of which will be showcased at this meeting. The Symposium will feature international leaders and opinion makers in regeneration biology, as well as the emerging leaders in this field in Australia.

Confirmed international speakers include:

Ahsan Husain
Professor of Medicine, Division of Cardiology, Emory University School of Medicine,
Atlanta, Georgia, USA

Professor Husain will deliver the Princesses’ Lecture on Thyroid hormone pathways and cardiac growth.

Bernard Kuhn
Principle Investigator, the Richard King Mellon Foundation, Children’s Hospital of
Pittsburgh; Associate Professor and Director of Research in Cardiology, Department of
Pediatrics, University of Pittsburgh School of Medicine, Pennsylvania, USA

Nadia Rosenthal
Scientific Director, The Jackson Laboratory, Bar Harbor, Maine, USA; Chair in
Cardiovascular Science, Imperial College London, UK

Nenad Bursac
Professor of Biomedical Engineering, Duke University, Durham, North Carolina, USA

Didier Stainier
Director, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany

Elly Tanaka
Director, DFG Research Centre/Cluster of Excellence, Centre for Regenerative
Therapies, Dresden University of Technology, Dresden, Germany

Eldad Tzahor
Associate Professor, Department of Biological Regulation, Weizmann Institute of
Science, Rehovot, Israel

Karina Yaniv
Principal Investigator, Department of Biological Regulation, Weizmann Institute of
Science, Rehovot, Israel





Some of the world’s greatest heart and lung transplant specialists presented their fascinating research at the 16th International Victor Chang Symposium in Sydney. The theme was “A Change of Heart, A Breath of Fresh Air”.

PROGRAM: 2015 Victor Chang Symposium Program

Princesses’ Lecturer

Professor Peter Macdonald
Victor Chang Institute, Sydney
St Vincent’s Hospital, Sydney

 International Speakers

Mr Stephen Large
Papworth Hospital, United Kingdom

Dr Darren Freed
University of Alberta Hospital, Canada

Dr Gopala Krishna Gokhale Alla
Yashoda Hospital, India

Professor Sandrine Lecour
Hatter Institute,
University of Cape Town, South Africa

Mr Andre Simon
Harefield Hospital, UK

Professor Dirk Van Raemdonck
University Hospitals Leuven, Belgium

National Speakers

Professor Frank Rosenfeldt
Monash University, Melbourne

Dr Daniel Chambers
Northside Heart and Lung, Queensland

Dr Greg Snell
Dr Bronwyn Levvey
Dr David McGiffin
The Alfred Hospital, Melbourne

Dr Katrina Bramstedt
Bond University, Queensland

Dr Rob Larbalestier
Heart & Lung Transplant Institute, Perth



aCVM_0290_Victor Change - Public Lecture 2014 Web 501x235

The 15th International Victor Chang Symposium, in conjunction with St Vincent’s Hospital, was held from Thursday 23 – Saturday 25 October, 2014.
The theme of the Symposium was “Unlocking the genetic code of heart disease”.

Venue: NAB Auditorium, L2 Garvan Building, 384 Victoria St, Darlinghurst, Sydney, NSW 2010.

Leslie Leinwand, Princesses Lecturer 2014

Leslie Leinwand, Princesses’ Lecturer


The Symposium will also incorporate the 2014 Princesses’ Lecture, to be given by Leslie Leinwand (pictured left) from University of Colorado, Boulder, USA.

The Symposium program will span the gamut from basic science to clinical medicine.  Sessions will focus on heart development and congenital heart disease, genetic basis of dilated cardiomyopathy, cardiac muscle function and new therapies, mechanisms of cardiac hypertrophy, cardiac regeneration and stem cells, and new heart failure therapies.

CONFIRMED International Speakers

CONFIRMED National Speakers

CONFIRMED Local Speakers

Please register today using this form.

Parking in Darlinghurst: Bayswater Road Secure Parking Station (24 hours); 33 Bayswater Road, 2011 Grimes – St Vincent’s Hospital Carpark; Entry Victor Street, Darlinghurst – next drive way to emergency entry.

For further information or sponsorship enquiries, please contact Ms Tanya Perre on P: +61 (2) 9295 8761 or E:

With thanks to our sponsors:

VCCRI_20year_logo_PMS res


edited clearview

The Public Lecture has been kindly sponsored by ClearView Wealth Limited. ClearView provides a comprehensive range of investment, superannuation, retirement and life insurance solutions as well as financial advice. It has been helping individuals, families and businesses achieve financial security and peace of mind for nearly 40 years.

ClearView is proud to be the major sponsor of the Victor Chang Public Lecture ‘Everyone Deserves a Perfect Heart’. To find out more about how ClearView can help you achieve a better financial future talk to your financial adviser today, call us on 132 976 or visit


The Victor Chang Institute would also like to thank:



Novartis RGB


Menarini Logo


Servier Lab Aus


Latest news


World renowned scientist Professor Roland Stocker from the Victor Chang Institute has been...
Find out more

Latest event


2016 Women Against Heart Disease Lunch   in memory of Monica O’Loughlin...
Find out more

Latest article


1984 Tamworth teen Fiona Coote, 14, becomes Australia's youngest and first female...
Find out more

Latest media

Life Changing Diagnosis

Find out more


Do you have a question but cannot find the answer?

ask the institute

Privacy Policy

1. Our privacy commitment

The Victor Chang Cardiac Research Institute respects your privacy.

We collect, store and use your personal information to help us fight heart disease. This Privacy Policy explains how we handle the personal information we collect relating to our fundraising activities – this includes marketing, events, our website, and health promotion services such as the Health Check Booth.

2. What types of personal information we collect

Personal information means information that identifies you or that could reasonably be used to identify you. The types of personal information we collect may include your name, gender, contact information, email address, credit/debit card information and if you consent to take part in our activities and events, health promotion services or to receive marketing materials from us.

3. Health information and other sensitive information

We do not collect health information or other types of sensitive information as part of our general fundraising activities or through our general web-site.

4. Using unsolicited information

Unsolicited information is information that is given to us that we haven’t asked for, from you or anyone else. If we receive this type of information, we will check whether this information is reasonably necessary for what we do. If it is, we’ll handle this information in the same way we do all personal information under privacy laws. If we don’t need it we’ll destroy or de-identify it.

5. How we collect your personal information

Where possible, we will collect your personal information directly from you. This may be in person (e.g. when you attend an event), on the telephone, or on-line.

We only collect information by lawful and fair means.

We may also obtain personal information from third parties or publicly available sources. In this case, we will take reasonable steps to contact you and ensure that you are aware of the circumstances surrounding the collection and purposes for which we collected your personal information.

6. Why we collect your personal information

We may collect your personal information for a number of purposes, including:

  • Marketing: to communicate with you about donations, our activities and fundraising events.
  • Health promotion: to provide you with services and information related to cardiovascular disease and its risk factors and research-related events and seminars.
  • Other activities: communicating with you to verify your identity, to improve and evaluate our programs and services, and to comply with relevant laws.

7. What happens if you don’t provide your information?

If you do not provide some or all of the personal information requested, we may not be able to offer you services, process your donations, or provide you with information about our events and activities.

8. Using a pseudonym or engaging with us anonymously

Anonymous donations may be made to the Victor Chang Cardiac Research Institute at any time by contacting us directly. Please note that we are unable to provide anonymous donors with receipts.

If you want to make a general enquiry or browse our web-site you can do so anonymously.

9. Website usage information and cookies

We do not use ‘cookies’ or any other methods to record information that is personally identifiable such as a visitor’s contact details, IP address, or domain name. We do use ‘cookies’ to anonymously track visits to our web pages and the documents that are downloaded in order to compile statistical information. This provides us with information about which pages are popular. If you prefer for ‘cookies’ not to be used, you can set your browser to disable them.

10. When we disclose your personal information

We may need to disclose your personal information to our agents in order to carry out our fundraising activities. This may include agencies who perform services on our behalf, such as mailing houses, printers, information technology services providers, archiving services, database services and telemarketing agencies. These services will always be provided under strict confidentiality agreements.

In rare cases, we may be required by law to disclose your information to a government or law enforcement agency (for example to investigate an allegation of credit card fraud).

11. Security of our information

We take all reasonable steps to protect the personal information we hold from misuse, interference and loss, and from unauthorised access. Electronic information is stored on secure servers that are protected in controlled facilities.

We do not use data hosting facilities or third party service providers that store information overseas.

Hard copy information is generally stored in our offices, which are secured to prevent entry by unauthorised people. Any personal information not actively being used is archived, usually for 7 years, with a third party provider of secure archiving services. Where personal information is stored with a third party, we have strict agreements in place that require those third parties to maintain the security of the information.

12. Security of direct debit and credit card information

We use a third-party financial institution to process our credit card transactions. It receives the credit card number and other personal information of our donors only to verify credit card numbers and to process credit card transactions in a secure environment. Where your financial information is stored on our servers, access to this information is restricted to our authorised staff only.

13. Accessing or changing your personal information

We take reasonable steps to make sure that the information we collect and use is accurate, up-to-date and complete. You may contact our Fund Development Officer at any time if you wish to:

  • change or correct your personal information (for example address or telephone number)
  • cancel some or all of the communications that we provide (we include opt-out mechanisms on the majority of our communications)
  • request access to the information that we hold about you
  • request further information about our privacy policy.

14. Questions and complaints

If you have any questions, concerns or complaints about the way in which we have handled your personal information, please contact our Fund Development Officer.

Once we receive a complaint, we will respond to you as soon as possible and will let you know if we need any further information from you. We will notify you of our decision within 30 days, however, if we are unable to do so, we will let you know the reason for the delay and the expected timeframe for resolving the complaint.

You may also lodge a complaint with the Office of Australian Information Commissioner, for more information visit

15. How to contact the Fund Development Officer



Victor Chang Cardiac Research Institute
PO Box 699
Darlinghurst NSW 2010

Telephone 1300 842 867

For a copy of our full privacy policy, please click here.

Updated: March 2014